The Highly Anticipat
The Highly Anticipated FDA Approvals of Galderma’s Nemolizumab and Eli Lilly’s Lebrikizumab are Expected to Shift Dermatologists’ Perceptions of the Atopic Dermatitis Market
September 09, 2024 10:20 ET | Spherix Global Insights
EXTON, PA, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Since its 2017 debut as the first advanced systemic treatment for atopic dermatitis (AD), Sanofi/Regeneron’s Dupixent has dominated the US market....
US Hematologists Exp
US Hematologists Express High Unmet Need in Treatments for Warm Autoimmune Hemolytic Anemia and Cold Agglutinin Disease
July 24, 2024 14:00 ET | Spherix Global Insights
EXTON, PA, July 24, 2024 (GLOBE NEWSWIRE) -- Autoimmune hemolytic anemia (AIHA) encompasses a group of rare disorders characterized by the destruction of red blood cells due to autoantibodies. Among...
Takeda’s Eohilia See
Takeda’s Eohilia Sees Strong Early Adoption and Growth Potential in Eosinophilic Esophagitis, According to Spherix Global Insights
July 18, 2024 10:05 ET | Spherix Global Insights
EXTON, PA, July 18, 2024 (GLOBE NEWSWIRE) -- In February of this year, Takeda’s Eohilia (budesonide oral suspension) received FDA approval as the first and only oral therapy for eosinophilic...
FluGen-logo-CMYK USE THIS ONE PNG.png
FluGen’s Intranasal M2SR Flu Vaccine, Co-Administered with High Dose Vaccine, in Older Adults Shows Superiority Over Flu Shot Alone
July 12, 2024 07:00 ET | FluGen, Inc.
Combining FluGen's M2SR nasal spray flu vaccine with Sanofi's Fluzone High Dose shot generates superior results in older adults versus the shot alone.
Final Logo-01.png
Antidiuretic Drugs Market Size & Share to Exceed USD 1504.8 Million by 2034, at CAGR of 11.5%. "Fluid Harmony: Navigating the Antidiuretic Drugs Market for Optimal Hydration Solutions" – PMI Leads the Way
February 01, 2024 15:00 ET | PMI
Covina, Feb. 01, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the Antidiuretic Drugs Market size was valued at about USD 558.7 Million in 2024 and expected to grow at CAGR of...
IMF_logo_RGB.png
The International Myeloma Foundation is Creating an Award-Winning Tool for Nurses to Improve Myeloma Patient Outcomes in Underserved Communities
November 02, 2023 13:15 ET | International Myeloma Foundation
The International Myeloma Foundation wins the 2023 Sanofi HealthEquity Accelerator Award for their program which empowers nurses and tackles disparities.
First-Wave-Logo-FINAL-RGB[1].jpg
First Wave BioPharma Announces Exclusive Global License Agreement for Capeserod from Sanofi
September 14, 2023 06:00 ET | First Wave BioPharma, Inc.
BOCA RATON, Fla., Sept. 14, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave” or the “Company”), a clinical-stage biopharmaceutical company specializing in the...
Final Logo-01.png
[PDF] Leprosy Treatment Market is estimated to be US$ 4.09 billion by 2030 with a CAGR of 4.50% during the forecast period – By PMI
September 05, 2023 14:30 ET | PMI
Covina, Sept. 05, 2023 (GLOBE NEWSWIRE) -- According to the latest research study, the demand of “Leprosy Treatment Market accounted for US$ 2.65 billion in 2020 and is estimated to be US$ 4.09...
Mordor Intelligence Logo_Comp.png
North America Diabetes Care Devices Market Revenues to Reach USD 35.02 Billion by 2028 - Market Size, Share, Forecasts, & Trends Analysis Report by Mordor Intelligence
August 21, 2023 09:30 ET | Mordor Intelligence
Hyderabad, Aug. 21, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled "North America Diabetes Care Devices Market Report (2023-2028)," the market is estimated at USD 25.91...
An Old Dog with a Ne
An Old Dog with a New Trick… Ellodi’s APT-1011 Promises EoE Patients a Convenient and Potent Treatment Alternative
August 15, 2023 15:40 ET | Spherix Global Insights
Exton, Pennsylvania, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Since launching in May 2022, Sanofi/Regeneron’s Dupixent has been well received by gastroenterologists and allergists as an advancement for...